Sigma receptors in schizophrenic cerebral cortices

[1]  L. Harris,et al.  Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain. , 1984, The Journal of pharmacology and experimental therapeutics.

[2]  Biochemical and behavioral characterization of PCP and sigma opioid receptors Contreras, P. C., R. P. Compton, J. B. Monahan and T. L. O'Donohue. Searle Research and Development, G. D. Searle & Co., St. Louis, MO 63198 , 1987, Pharmacology Biochemistry and Behavior.

[3]  L. Snell,et al.  Equilibrium analysis of [3H]TCP binding: effects of glycine, magnesium and N-methyl-D-aspartate agonists. , 1988, European journal of pharmacology.

[4]  N. Mataga,et al.  Neurotransmitters, receptors and neuropeptides in post‐mortem brains of chronic schizophrenic patients , 1988, Acta psychiatrica Scandinavica.

[5]  S. Mclean,et al.  Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain , 1988, Neuroscience.

[6]  Biochemical and behavioral aspects of sigma and phencyclidine receptors: similarities and differences Tam, S. W., G. F. Steinfels and L. Cook. Medical Products Department, E. I. du Pont de Nemours & Co., Wilmington, DE 19898 , 1987, Pharmacology Biochemistry and Behavior.

[7]  Edythe D. London,et al.  Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia , 1991, Biological Psychiatry.

[8]  A. Romero,et al.  A proton NMR investigation of the influence of distal glutamine on structural and dynamic properties of elephant metmyoglobin. , 1984, The Journal of biological chemistry.

[9]  M. Williams,et al.  Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists. , 1986, European journal of pharmacology.

[10]  M. Toru,et al.  Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics , 2005, European archives of psychiatry and neurological sciences.

[11]  Y. Itzhak.  Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: Effects of N-methyl-d-aspartate agonists and antagonists , 1989, Neuroscience Letters.

[12]  Y. Itzhak.  Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites. , 1988, Life sciences.

[13]  T. Perry,et al.  CSF amino acids and plasma‐CSF amino acid ratios in adults 1 , 1975, Journal of neurochemistry.

[14]  S. Snyder,et al.  Novel antipsychotic drugs share high affinity for σ receptors , 1988 .

[15]  S. Tam.  Naloxone-inaccessible sigma receptor in rat central nervous system. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Sonders,et al.  Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action , 1988, Trends in Neurosciences.

[17]  R. Zukin,et al.  Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites. , 1981, Molecular pharmacology.

[18]  T. Su.  Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. , 1982, The Journal of pharmacology and experimental therapeutics.

[19]  C. Haertzen.  Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI) , 2004, Psychopharmacologia.

[20]  P. Contreras,et al.  Biochemical and behavioral effects of sigma and PCP ligands , 1988, Synapse.

[21]  S. Snyder,et al.  Phencyclidine and σ opiate receptors in brain: Biochemical and autoradiographical differentiation , 1985 .

[22]  S. Snyder,et al.  Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Hedreen,et al.  Sigma receptors in post-mortem human brains. , 1988, The Journal of pharmacology and experimental therapeutics.

[24]  S. Snyder,et al.  Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. , 1986, The Journal of pharmacology and experimental therapeutics.

[25]  K. Brady,et al.  Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats. , 1982, Science.

[26]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.

[27]  M. Sonders,et al.  1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Tam,et al.  Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[29]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[30]  S. Snyder,et al.  Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1- propyl)piperidine , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  S. Snyder,et al.  Novel antipsychotic drugs share high affinity for sigma receptors. , 1988, European journal of pharmacology.

[32]  D. Rodbard,et al.  Differential modulation by cations of sigma and phencyclidine binding sites in rat brain. , 1990, Journal of receptor research.

[33]  T. Perry,et al.  REGIONAL DISTRIBUTION OF AMINO ACIDS IN HUMAN BRAIN OBTAINED AT AUTOPSY , 1971, Journal of neurochemistry.